A flexible protocol for the preparation of model substances for uronic acid containing polysaccharides is presented. We have synthesized a D-glucuronic acid derivative which is designed so that it easily can be conjugated with different structures and architectures by selective Michael-type addition. By successful coupling of the glucuronic acid derivative to polyethylene glycol with high degree of conversion, products were obtained that were easily characterized and which resembled polysaccharides in terms of solubility and purification methods that could be employed. The model substance can potentially be used to facilitate optimization of low-degree modification reactions of high molecular weight D-glucuronic acid containing polysaccharides.
Introduction
Hydrogels are generally considered to be well suited as scaffolds for cell and tissue engineering applications due to their similarity to the natural extra cellular matrix [1] [2] [3] [4] . Naturally occurring polysaccharides such as hyaluronic acid (hyaluronan) have received special attention for such purposes due to their biocompatibility and physiochemical properties [5] . Cross-linking of hyaluronic acid is a means to obtain an implantable hydrogel with controlled degradability and mechanical properties [6] [7] [8] . However, many cross-linking techniques employed today suffer drawbacks due to large degree modifications, which are necessary to compensate for the large extent of intramolecular reactions that occur when bifunctional cross-linkers are used [9] . In order to maintain the immunoneutrality and unique properties of native hyaluronic acid, it is suggested that the cross-linkable derivative should be modified to a low degree and synthesized under controlled conditions to avoid unwanted and unnecessary side reactions during modification and cross-linking. The degree of modification that can be performed without significantly altering properties of native hyaluronic acid depends on the type of modification and is a matter that deserves greater attention, although it is not a subject of further discussion in this report. Derivatives of uronic acid containing polysaccharides of high molecular weight which are modified to a low degree are difficult to characterize. To address this issue we have developed a synthetic protocol for the preparation of a model substance consisting of a novel D-glucuronic acid derivative that is conjugated with polyethylene glycol (PEG) (Figure 1 ). D-glucuronic acid is found in the disaccharide repeat unit of hyaluronic acid and contains both a carboxylic acid and hydroxyl groups, which are the main targets for performing modifications. The model substance is an ideal candidate for optimizing modification reactions since the process can be followed by nuclear magnetic resonance (NMR), which otherwise is difficult due to the low degree of modification and high molecular weight of hyaluronic acid. Coupling the glucuronic acid derivative with PEG has added the feature to the model substance in the sense that it can be purified by techniques commonly used for polysaccharides, such as gel-filtration and dialysis. The glucuronic acid derivative is designed so that it can be easily combined with different structures and architectures by selective Michael-type addition, making it possible to obtain a substance easy to characterize yet large enough to handle purification wise.
Experimental procedures

Materials and methods
Polyethylene glycol with a molecular weight of 2000 g/mol (PEG2000), purchased from VWR, and polyethylene glycol diacrylate with a molecular weight of 700 Da (PEGDA700), from Aldrich, were used without further purification. Prior use, dichloromethane (VWR) was washed three times with de-ionized water, dried over MgSO 4 , filtered, refluxed over CaH 2 , distilled and stored over argon. Methanol (VWR) was refluxed over CaH 2 , distilled and stored over argon. All other chemicals were purchased of reagent grade or of higher purity from Aldrich, ACROS Organics, ABCR or VWR and were used without further purification. Column chromatography was performed on silica gel 60 G (Merck) and monitored by thin layer chromatography (TLC) on fluorescent silica gel coated plates (Merck). 1 H NMR and 13 C NMR analyses were performed on a JEOL ECP 400 MHz spectrometer with the solvent signal as an internal standard. FT-IR spectra were recorded on a Perkin-Elmer Spectrum One spectrometer. Molecular mass and molecular mass distribution of the final products were obtained by matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) using a Bruker UltraFlex system with a SCOUT-MTP ion source (Bruker Daltonics, Bremen, Germany) operating in reflection mode and with 2,5-dihydroxybenzoic acid (DHB) as matrix. Samples were prepared in de-ionized water by mixing 5 µl of product (1 mg/ml) with 20 µl of DHB (10 mg/ml). Melting point was determined by differential scanning calorimetry (DSC-Q1000, TA Instruments).
Synthesis of PEG diacrylate
PEG2000 (5 g) was dissolved in 100 ml toluene and dried azeotropically. Toluene was removed by rotary evaporation and the residue dried in vacuum. The dried polymer (1 g, 1 mmol functional groups) was dissolved in 10 ml freshly distilled dichloromethane under nitrogen while cooling in an icebath. To the solution was added 0.25 ml acrylic anhydride (2.2 mmol) and 0.3 ml triethylamine (2.2 mmol) and the reaction proceeded while stirring in the dark overnight at room temperature. The volume of the solution was reduced by rotary evaporation and the product (PEGDA2000) was collected by precipitation in cold diethyl ether, filtered and dried in vacuum. Yield: 89%. 1 
Synthesis of methyl (benzoyl 2,3,4-tri-O-benzoyl-α α-D-glucopyranoside) uronate, 1
To a solution of powdered NaOH (20 mg, 0.5 mmol) in 40 ml freshly distilled methanol was added 4 g D-glucofurano-6,3-lactone (22.7 mmol) followed by stirring in room temperature for 10 hours. The solution was concentrated by evaporation, the residue dissolved in 50 ml pyridine and cooled to 0°C. Benzoyl chloride (16 ml, 139 mmol) was added to the solution and stirred at room temperature overnight. The reaction mixture was diluted with 40 ml ice-cold de-ionized water and 400 ml dichloromethane, and then washed with saturated aqueous NaHCO 3 and water. The organic phase was dried over Na 2 SO 4 and concentrated by evaporation. The residue was purified by flash silica chromatography [heptane -ethyl acetate (3:2)] to give 1 as a mixture of the α and β anomers, 9.35 g (66% 
Synthesis of methyl (2,3,4-tri-O-benzoyl-α α-D-glucopyranosyl bromide) uronate, 2
To 9 g of 1 (14.4 mmol) was added 36 ml HBr (33% in acetic acid) followed by stirring in room temperature for 12 hours. The mixture was cooled to 0°C, diluted with 180 ml ice-cold dichloromethane and washed with saturated aqueous NaHCO 3 , de-ionized water and brine. The organic phase was dried over MgSO 4 , concentrated by evaporation and the residue dried in vacuum to give 2, 7.8 g (93% 
Synthesis of methyl (3-thioacetoxypropyl 2,3,4-tri-O-benzoyl-β β-D-glucopyranoside) uronate, 4
To a solution of 41 mg 2,2′-Azobis(2-methylpropionitrile) (AIBN, 0.25 mmol) in 8.5 ml dioxane was added 560 mg of 3 (1 mmol). The solution flask was flushed with argon gas and cooled on ice, and 1.1 ml thioacetic acid (15.3 mmol) added. The mixture was subjected to a freeze-vacuum-thaw process three times, purged with argon gas and stirred at 75°C for 4 hours. The reaction was quenched by flushing with air, the solution concentrated by evaporation from toluene and the product purified by flash silica chromatography [hexaneethyl acetate (gradient, 95-67% hexane)] to give 4, 390 mg (61% 
Synthesis of PEG diglucuronic acid, 5a and 5b
To a sealed round-bottomed flask thoroughly purged with nitrogen gas containing 150 mg of 4 (0.24 mmol) was added a degassed methanol -deionized water mixture (5:1, 9 ml). The mixture was heated to 55°C and stirred until dissolution before cooling in ice and adding 1.5 ml degassed 3 M NaOH. After stirring at room temperature for 6 hours the solution was transferred to Dowex H + 50×8-100 sulfonic resin (Aldrich) in a sealed flask flushed with nitrogen gas and stirred at room temperature for 20 minutes. The solution was transferred to a sealed flask flushed with nitrogen gas, containing 50 mg PEGDA700 (0.14 mmol functional groups). A degassed 0.5 M NaHCO 3 -solution was added until pH 9 was reached and the flask was agitated at room temperature for 15 hours. Methanol was removed by evaporation and the residue purified by gel-filtration using a Sephadex-G25 PD-10 pre-packed column (Amersham Biosciences). 
Results and discussion
The model substance is versatile in the sense that the glucuronic acid derivative easily can be combined with appropriate macromolecules through a selective Michael-type addition that previously has been described by Lutolf et al. [10] . In this study PEG was chosen, which simplifies characterization with NMR spectroscopy due to the absence of functional groups on the main chain and brings properties to the model substance resembling hyaluronic acid in terms of solubility and purifica- The strategy employed for synthesizing the model substance ( Figure 3 ) involved five steps beginning with the preparation of a benzoyl protected glucopyranoside uronate as a mixture of the α and β anomers (1), which further was converted to an α bromide (2) using methods previously published by Figure 4 . 1 H NMR spectra of compounds 1-5a recorded at 400 MHz. Peaks for substance 5a are assigned labels according to IUPAC nomenclature Coutant and Jacquinet [11] . In the following step allyl alcohol was introduced to the bromide, which proved most successful by the classical KoenigsKnorr glycosylation in the presence of silver carbonate [12] . Radical elongation of 3 with thioacetic acid afforded 4, which was further converted to a thiol and simultaneously deprotected by treatment of sodium hydroxide under nitrogen while cooling. Deprotection performed without cooling, under otherwise same conditions, resulted in the formation of β-elimination product. An excess of the thio-glycoside was coupled with PEGDA under nitrogen without prior purification in order to avoid disulfide formation, and resulted in high yields of product (5a and 5b). Although disulfides are readily formed in the presence of oxygen, thiols have shown to be ideal for the Michael-type addition to unsaturated esters [10] . The products were appropriately purified to remove salts and excess starting material. Characterization of the final products (5a and 5b) with NMR spectroscopy confirmed a high purity and a full conversion, as indicated by the complete absence of signals from acrylate protons and by the ratio of integrated signals originating from the anomeric protons on the glucuronic acid moieties (δ = 4.48 ppm) and protons on the main chain of PEG (δ = 3.65 ppm). A typical 1 H NMR spectrum of the model substance (5a) is demonstrated in Figure 4 , along with spectra for compounds 1-4. Performing COSY NMR experiments enabled assignment of overlapping signals. MALDI-TOF MS was used to determine molecular mass and molecular mass distributions of the conjugates, which also confirmed a high conversion degree. A typical MALDI-TOF mass spectrum of the model substance with uniformly distributed 44 g/mol spaced lines attributed to the PEG repeat unit is provided in Figure 5 . On one hand, the higher molecular weight conjugate (5b) has the advantage of being solid at room temperature, adding the possibility to purify by precipitation. On the other hand a model substance with lower molecular weight (e.g. 5a) is preferred characterization wise. In addition to use the glucuronic acid derivative as model substances for optimizing modification reactions, it may be used for the preparation of glycoconjugates that are of interest in the study of the biological role of carbohydrates. Although the described model substance currently is used for the development of new crosslinking chemistry for hyaluronic acid, it may also be applied for other D-glucuronic acid containing polysaccharides such as chondroitin sulfate, heparin and heparan sulfate.
Conclusions
A protocol for the preparation of a model substance for uronic acid containing polysaccharides has been developed. The model substance consists of a D-glucuronic acid -PEG conjugate which was synthesized in five steps. Selective Michael-type addition enabled coupling of the thiolated D-glucuronic acid derivative with full conversion to PEG-diacrylate of two different molecular weights. By conjugating the glucuronic acid derivative with different structures and architectures it is possible to obtain model substances which resemble polysaccharides while at the same time are easier to characterize. We believe that the protocol is a flexible route to the preparation of model substances which can be used in the optimization of modification reaction for high molecular weight polysaccharides. 
